Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout
2019 · Clinical Pharmacology & Therapeutics · 6 citations
https://doi.org/10.1002/cpt.1454